Sphingomab TM

Related by string. * : Sphingomab / TMD . Tm . TMs . TMS . tm : FinancialWire tm website . Contact FinancialWire tm . TM EA SPORTS . Forrester Wave TM . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM . through eReleases TM . Impart IQ TM . AMD Opteron TM . ICO mim TM . Onko Sure TM . Solaris TM . Augment TM . FinancialWire tm . deCODE Glaucoma TM * *

Related by context. Frequent words. (Click for all words.) 69 Initiates Phase II 68 Panzem R 68 proteasome inhibitor 67 liposomal formulation 67 Nanobody 67 targeting CD# 67 Guanilib 66 ALN TTR 66 humanized antibody 66 Zolinza 66 Factor VIIa 66 multi kinase inhibitor 66 refractory chronic lymphocytic 66 HCV protease inhibitor 65 Epratuzumab 65 pertuzumab 65 Receives Orphan Drug Designation 65 cancer immunotherapies 64 theranostic 64 ATL# [001] 64 therapeutic monoclonal antibodies 64 Tesetaxel 64 TLR9 agonist 64 humanized anti 64 R sorafenib tablets 64 Carfilzomib 64 humanized monoclonal antibody 64 phase IIb clinical 64 vascular disrupting agent 64 Belimumab 64 MVA BN R 64 KNS # 64 Initiate Phase 63 T#I [002] 63 Drug Candidate 63 immunologic diseases 63 vosaroxin 63 elotuzumab 63 histone deacetylase 63 BZL# 63 novel orally administered 63 antisense drug 63 PEGylated 63 PEG SN# 63 MEK inhibitor 63 JAK1 63 GVAX R 63 Soliris TM eculizumab 63 gets USFDA nod 63 novel RNAi therapeutics 63 ASONEP 63 FDA Accepts 63 theranostics 63 otelixizumab 63 orally bioavailable 63 ZFP Therapeutic 63 predictive biomarkers 63 fibrosis IPF 62 immune modulator 62 Dapagliflozin 62 AEG# 62 immunotherapeutics 62 bioactive lipids 62 immunotherapeutic 62 Aliskiren 62 exon skipping 62 Onalta 62 TACI Ig 62 DermaVir 62 immunological diseases 62 Chemokine Therapeutics 62 anti fibrotic 62 angiogenesis inhibitor 62 oncolytic 62 PSN# [002] 62 CCX# 62 Daclizumab 62 epothilone 62 Pralatrexate 62 molecularly targeted 62 Nanobodies 62 Mipomersen 62 prophylactic vaccine 62 polymerase inhibitor 62 deforolimus 62 rNAPc2 62 IMC #B 62 Presents Positive 62 inhaled formulation 62 mTOR inhibitor 62 antibody fragment 62 Myelofibrosis 62 commercializing therapeutic 62 CD# antibody [001] 62 novel antibody therapeutics 61 mimetics 61 Recombinant Human 61 HGS ETR2 61 multiple myeloma MM 61 Metastatic Melanoma 61 anticancer compound

Back to home page